Cargando…
Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment
Recently, Achyranthis radix extract has been studied as a therapeutic agent for dry eye disease that occurs from fine dust. The aim of this study was the development of Achyranthis radix extract-loaded eye drop formulations using lubricants, generally used for artificial tear eye drops. Ecdysterone...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076473/ https://www.ncbi.nlm.nih.gov/pubmed/32079194 http://dx.doi.org/10.3390/pharmaceutics12020165 |
_version_ | 1783507225039339520 |
---|---|
author | Kim, Sung-Jin Park, Bongkyun Huh, Hyun Wook Na, Young-Guk Kim, Minki Han, Mingu Lee, Hyunmin Pham, Thi Mai Anh Lee, Hong-Ki Lee, Jae-Young Kim, Chan-Sik Baek, Jong-Suep Cho, Cheong-Weon |
author_facet | Kim, Sung-Jin Park, Bongkyun Huh, Hyun Wook Na, Young-Guk Kim, Minki Han, Mingu Lee, Hyunmin Pham, Thi Mai Anh Lee, Hong-Ki Lee, Jae-Young Kim, Chan-Sik Baek, Jong-Suep Cho, Cheong-Weon |
author_sort | Kim, Sung-Jin |
collection | PubMed |
description | Recently, Achyranthis radix extract has been studied as a therapeutic agent for dry eye disease that occurs from fine dust. The aim of this study was the development of Achyranthis radix extract-loaded eye drop formulations using lubricants, generally used for artificial tear eye drops. Ecdysterone was used as a marker compound for Achyranthis radix extract and 1% Achyranthis radix extract solution contained 14.37 ± 0.04 μg/mL of ecdysterone. Before formulation studies, a new method was performed to evaluate pigmentation, which might be caused by eye drops of herbal extract. A comparative study of the water retention ability of each formulation and ability to prevent the death of conjunctival epithelial cells in dry conditions was conducted. Moreover, treatment of Achyranthis radix extract (USL) eye drop formulation exhibited a significant inhibitory effect on inflammation in a concentration-dependent manner. The long-term and accelerated stability tests showed that lubricants could contribute to the stability of herbal extracts in solution. In conclusion, hyaluronic acid showed a good effect on the development of eye drop formulation using Achyranthis radix extracts for treating dry eye disease. |
format | Online Article Text |
id | pubmed-7076473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70764732020-03-20 Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment Kim, Sung-Jin Park, Bongkyun Huh, Hyun Wook Na, Young-Guk Kim, Minki Han, Mingu Lee, Hyunmin Pham, Thi Mai Anh Lee, Hong-Ki Lee, Jae-Young Kim, Chan-Sik Baek, Jong-Suep Cho, Cheong-Weon Pharmaceutics Article Recently, Achyranthis radix extract has been studied as a therapeutic agent for dry eye disease that occurs from fine dust. The aim of this study was the development of Achyranthis radix extract-loaded eye drop formulations using lubricants, generally used for artificial tear eye drops. Ecdysterone was used as a marker compound for Achyranthis radix extract and 1% Achyranthis radix extract solution contained 14.37 ± 0.04 μg/mL of ecdysterone. Before formulation studies, a new method was performed to evaluate pigmentation, which might be caused by eye drops of herbal extract. A comparative study of the water retention ability of each formulation and ability to prevent the death of conjunctival epithelial cells in dry conditions was conducted. Moreover, treatment of Achyranthis radix extract (USL) eye drop formulation exhibited a significant inhibitory effect on inflammation in a concentration-dependent manner. The long-term and accelerated stability tests showed that lubricants could contribute to the stability of herbal extracts in solution. In conclusion, hyaluronic acid showed a good effect on the development of eye drop formulation using Achyranthis radix extracts for treating dry eye disease. MDPI 2020-02-17 /pmc/articles/PMC7076473/ /pubmed/32079194 http://dx.doi.org/10.3390/pharmaceutics12020165 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Sung-Jin Park, Bongkyun Huh, Hyun Wook Na, Young-Guk Kim, Minki Han, Mingu Lee, Hyunmin Pham, Thi Mai Anh Lee, Hong-Ki Lee, Jae-Young Kim, Chan-Sik Baek, Jong-Suep Cho, Cheong-Weon Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title | Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title_full | Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title_fullStr | Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title_full_unstemmed | Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title_short | Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment |
title_sort | achyranthis radix extract-loaded eye drop formulation development and novel evaluation method for dry eye treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076473/ https://www.ncbi.nlm.nih.gov/pubmed/32079194 http://dx.doi.org/10.3390/pharmaceutics12020165 |
work_keys_str_mv | AT kimsungjin achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT parkbongkyun achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT huhhyunwook achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT nayoungguk achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT kimminki achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT hanmingu achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT leehyunmin achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT phamthimaianh achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT leehongki achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT leejaeyoung achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT kimchansik achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT baekjongsuep achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment AT chocheongweon achyranthisradixextractloadedeyedropformulationdevelopmentandnovelevaluationmethodfordryeyetreatment |